Related Experiment Video
Updated: May 1, 2026
09:49
Routine Screening Method for Microparticles in Platelet Transfusions
Published on: January 31, 2018
16.4K
Thrombosis, platelets, microparticles and PAH: more than a clot
Katie L Lannan1, Richard P Phipps2, R James White3
1Department of Microbiology and Immunology, University of Rochester, 601 Elmwood Ave, Rochester, NY 14642, USA.
Drug Discovery Today
|April 22, 2014
Summary
Pulmonary arterial hypertension (PAH) involves blood clotting and platelet issues. This review explores how coagulation, thrombosis, and microparticles contribute to PAH progression.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Pulmonary Medicine
Background:
- Pulmonary arterial hypertension (PAH) is a progressive disease characterized by vascular remodeling, vasoconstriction, and thrombosis.
- Hemostasis, coagulation, and platelet activation are frequently altered in PAH patients.
- Microparticles from platelets, inflammatory cells, and endothelium are recognized signals in cardiovascular diseases, including PAH.
Purpose of the Study:
- To review the roles of coagulation, thrombosis, platelet activation, and microparticles in PAH.
- To highlight the contribution of these hemostatic factors to the pathology and progression of PAH.
Main Methods:
- Literature review focusing on coagulation, thrombosis, platelet activation, and microparticles in PAH.
- Synthesis of current understanding of these factors in PAH pathogenesis.
Main Results:
- Coagulation and thrombosis are integral to PAH pathology.
- Platelet activation and microparticle formation are consistently observed in PAH.
- These hemostatic alterations contribute to vascular remodeling and disease progression.
Conclusions:
- Coagulation, thrombosis, platelet activation, and microparticles are key players in PAH.
- Targeting these pathways may offer therapeutic strategies for PAH.
Related Concept Videos
01:18Structure and Function of Platelets
7.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
7.1K
01:30Venous Thrombosis I: Introduction
822
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
822
01:16Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
01:22Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
01:09Coagulation
8.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.4K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K